Skip to main content
Home
  • Get Updates
  • Members and Providers
    • Member
    • Provider
      • Who We Serve: Overview
      • Consultants
      • Employers
      • Federal
      • Health Plans
      • Hospitals and Health Systems
      • Labor Unions
      • Public Sector
      • Members
      • Providers
      • Health Plans
      • Employers
      • Consultants
      • Labor Unions
      • Federal
      • Public Sector
      • Hospitals & Health Systems
      • Providers
      • Lower Costs
      • Improve Outcomes
      • Expand Access
      • Increase Member Engagement
      • Musculoskeletal
      • Behavioral Health
      • Oncology
      • Cardiovascular Disease
      • Diabetes
      • Obesity
      • Women’s Health and Family Planning
      • Pharmacy
      • Specialty
      • Express Scripts by Evernorth
      • Express Scripts Pharmacy by Evernorth
      • Accredo by Evernorth
      • EviCore by Evernorth
      • CuraScript SD by Evernorth
      • MyMatrixx by Evernorth
      • Freedom Fertility by Evernorth
      • MD Live by Evernorth
      • Insights
      • Newsroom
      • Behavioral Health
      • Gene Therapy
      • GLP-1s
      • Health Equity
      • Oncology
      • Women's Health
      • Health Care in Focus
      • Importance of Vitality
      • Pharmacy in Focus
      • Women's Health Report
      • Youth Mental Health
      • Evernorth Research Institute
      • The Lab by Evernorth
    • Why Evernorth?
    • About Us
    • Careers
  • Get Updates
  • Members and Providers
    • Member
    • Provider
Close search filters
info
Changing filters will change the listed Success Criteria and Techniques

Category
  • All Results
  • (-) article (343)
  • expert (75)
  • event (1)
  • topic pages (7)
  • page (173)
  • report (15)

Topic
  • Accredo
  • CuraSciptSD
  • eviCore
  • Express Scripts PBM
  • Express Scripts Pharmacy
  • Freedom Fertility
  • Inside Rx
  • MDLIVE

Search results (343)
Filter By
Article
How Evernorth's Clinical Trials team connects people to potentially lifesaving treatments
August 09, 2023
We sat down with Ria Westergaard, director of product innovation and a pharmacist who leads Evernorth's Clinical Trials team, to better understand the work her team does and how it improves patient ou...
Read more
Newsroom
Express Scripts Names Head of Independent Pharmacy Affairs to Deepen Partnerships, Expand Access to Care
August 08, 2023
Dr. Stephanie Smith Cooney will establish Express Scripts’ Office of Independent Pharmacy Enablement and lead the industry’s first Independent Pharmacy Advisory Committee
Read more
Newsroom
MDLIVE Intergenerational Study Shows Mental Health of American Families At-Risk
August 09, 2023
Read more
Article
The Lab by Evernorth: Turning data into insights to improve the health and vitality of those we serve
November 02, 2023
Read more
Article
""

Gene therapies: Million-dollar miracles

Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...

August 31, 23

Read More
Article
The importance of utilization management within the medical benefit
August 17, 2023
The ever-evolving complexity of medications billed through the medical benefit requires continuous investment in processes to manage their increasingly high price tag.
Read more
Report
Study: Cardiodiabesity prevention key to improving health outcomes and lowering costs
November 25, 2024
The Evernorth Research Institute analyzed aggregated and anonymized data of almost 5 million insured individuals to understand the prevalence of "cardiodiabesity" — a condition which encompasses cardi...
Read more
Article
""

Improving access to care for rural Americans by supporting and empowering independent pharmacies

We sat down with Adam Kautzner, a pharmacist and the president of Express Scripts, who discussed some of our recent endeavors to improve access to quality care in rural America.

August 23, 23

Read More
Article
Boosting Biosimilars Competition and Savings
September 25, 2023
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Read more
Article
Designing plans to manage comorbid conditions
August 25, 2023
Health plans that address and manage complex chronic conditions such as cardiovascular disease, obesity, and diabetes have a competitive advantage.
Read more
  • Load More
Home

Footer Column 1

  • Solutions
  • News and Insights
  • Press Releases
  • Careers
  • About Us
  • Accreditation
  • Contact Us

Footer Column 2

  • Express Scripts by Evernorth
  • Express Scripts Pharmacy by Evernorth
  • Accredo by Evernorth
  • Freedom Fertility by Evernorth
  • EviCore by Evernorth
  • MyMatrixx by Evernorth

Footer Column 3

  • CuraScript SD by Evernorth
  • Evernorth Behavioral Care Group
  • Evernorth Care Group
  • Inside Rx
  • MD Live by Evernorth
Facebook Logo Instagram Logo Linkedin Logo YouTube Logo

 

Language Assistance

Español [PDF]  |  中文 [PDF]  |  Tiếng Việt [PDF]  |  한국어 [PDF]  |  Tagalog [PDF]  |  Русский [PDF]   |  العربية [PDF]  |  Kreyòl [PDF]

Français [PDF]  |  Português [PDF]  |  Polski [PDF]  |  日本語 [PDF]  |  Italiano [PDF]  |  Deutsch [PDF]  |  فارسی [PDF]  |  More… [PDF]

 

Availability of programs and services may vary by location and is subject to change.

© 2025 Evernorth Health, Inc. All rights reserved. One Express Way, St. Louis, MO 63121
All products and services are provided by or through operating subsidiaries or affiliates of Evernorth.

 

Terms of Use Privacy Notice Notice of Privacy Practices

Accessibility   Health Care Fraud   Nondiscrimination Notice    WA Consumer Health Data Privacy Notice

View all Evernorth Privacy Notices